Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?
Purpose The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone. Methods Women who had a MSAFP test fol...
Gespeichert in:
Veröffentlicht in: | Archives of gynecology and obstetrics 2016-04, Vol.293 (4), p.767-770 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 770 |
---|---|
container_issue | 4 |
container_start_page | 767 |
container_title | Archives of gynecology and obstetrics |
container_volume | 293 |
creator | Sharony, Reuven Dayan, Dikla Kidron, Debora Manor, Mira Berkovitz, Arie Biron-Shental, Tal Maymon, Ron |
description | Purpose
The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone.
Methods
Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared.
Results
166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption.
Conclusion
Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC. |
doi_str_mv | 10.1007/s00404-015-3905-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1774526069</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261525731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</originalsourceid><addsrcrecordid>eNp1kV9rFTEQxYNU7LX6AXyRQF_6sjr5f_eplNKrhYI-6HNIk9masrvZJrvSfnuzbFUQhEBmOL-cIXMIecfgAwMwHwuABNkAU41oQTXtC7JjUvAGDGNHZAftWoM2x-R1KfcAjO_3-hU55loqITTbkcfrQucfSLObY6Kpo4ObMY-upwXzMtA5UTeMMc3R065fYqAXh6-0LBPmmPIqb1yPP7Ev1NVDp4wh-rnK1a82d6Mb_RP1aZj66NdBYzl_Q152ri_49vk-Id8PV98uPzc3Xz5dX17cNF5KPjeKB9HqDttOBQAXOsM1dwJF_X9gTgajOrHXTu5RaOFuhTe-1j6IugfulTghZ5vvlNPDgmW2Qywe-96NmJZimTFScQ26rejpP-h9WtZdFMu5ZoorI1il2Eb5nErJ2Nkpx8HlJ8vArrHYLRZbY7FrLHZ1fv_svNwOGP68-J1DBfgGlCqNd5j_jv6_6y-IXpfu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261525731</pqid></control><display><type>article</type><title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Sharony, Reuven ; Dayan, Dikla ; Kidron, Debora ; Manor, Mira ; Berkovitz, Arie ; Biron-Shental, Tal ; Maymon, Ron</creator><creatorcontrib>Sharony, Reuven ; Dayan, Dikla ; Kidron, Debora ; Manor, Mira ; Berkovitz, Arie ; Biron-Shental, Tal ; Maymon, Ron</creatorcontrib><description>Purpose
The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone.
Methods
Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared.
Results
166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption.
Conclusion
Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.</description><identifier>ISSN: 0932-0067</identifier><identifier>EISSN: 1432-0711</identifier><identifier>DOI: 10.1007/s00404-015-3905-9</identifier><identifier>PMID: 26453361</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; alpha-Fetoproteins - analysis ; Amniocentesis - methods ; Amniotic Fluid - chemistry ; Biomarkers - analysis ; Biomarkers - blood ; Endocrinology ; Female ; Fetal Growth Retardation - blood ; Gynecology ; Human Genetics ; Humans ; Maternal Serum Screening Tests ; Maternal-Fetal Medicine ; Medicine ; Medicine & Public Health ; Obstetrics/Perinatology/Midwifery ; Pregnancy - blood ; Pregnancy Complications ; Prenatal development ; Retrospective Studies</subject><ispartof>Archives of gynecology and obstetrics, 2016-04, Vol.293 (4), p.767-770</ispartof><rights>Springer-Verlag Berlin Heidelberg 2015</rights><rights>Archives of Gynecology and Obstetrics is a copyright of Springer, (2015). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</citedby><cites>FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00404-015-3905-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00404-015-3905-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26453361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharony, Reuven</creatorcontrib><creatorcontrib>Dayan, Dikla</creatorcontrib><creatorcontrib>Kidron, Debora</creatorcontrib><creatorcontrib>Manor, Mira</creatorcontrib><creatorcontrib>Berkovitz, Arie</creatorcontrib><creatorcontrib>Biron-Shental, Tal</creatorcontrib><creatorcontrib>Maymon, Ron</creatorcontrib><title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</title><title>Archives of gynecology and obstetrics</title><addtitle>Arch Gynecol Obstet</addtitle><addtitle>Arch Gynecol Obstet</addtitle><description>Purpose
The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone.
Methods
Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared.
Results
166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption.
Conclusion
Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.</description><subject>Adult</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Amniocentesis - methods</subject><subject>Amniotic Fluid - chemistry</subject><subject>Biomarkers - analysis</subject><subject>Biomarkers - blood</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fetal Growth Retardation - blood</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Maternal Serum Screening Tests</subject><subject>Maternal-Fetal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>Pregnancy - blood</subject><subject>Pregnancy Complications</subject><subject>Prenatal development</subject><subject>Retrospective Studies</subject><issn>0932-0067</issn><issn>1432-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kV9rFTEQxYNU7LX6AXyRQF_6sjr5f_eplNKrhYI-6HNIk9masrvZJrvSfnuzbFUQhEBmOL-cIXMIecfgAwMwHwuABNkAU41oQTXtC7JjUvAGDGNHZAftWoM2x-R1KfcAjO_3-hU55loqITTbkcfrQucfSLObY6Kpo4ObMY-upwXzMtA5UTeMMc3R065fYqAXh6-0LBPmmPIqb1yPP7Ev1NVDp4wh-rnK1a82d6Mb_RP1aZj66NdBYzl_Q152ri_49vk-Id8PV98uPzc3Xz5dX17cNF5KPjeKB9HqDttOBQAXOsM1dwJF_X9gTgajOrHXTu5RaOFuhTe-1j6IugfulTghZ5vvlNPDgmW2Qywe-96NmJZimTFScQ26rejpP-h9WtZdFMu5ZoorI1il2Eb5nErJ2Nkpx8HlJ8vArrHYLRZbY7FrLHZ1fv_svNwOGP68-J1DBfgGlCqNd5j_jv6_6y-IXpfu</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Sharony, Reuven</creator><creator>Dayan, Dikla</creator><creator>Kidron, Debora</creator><creator>Manor, Mira</creator><creator>Berkovitz, Arie</creator><creator>Biron-Shental, Tal</creator><creator>Maymon, Ron</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160401</creationdate><title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</title><author>Sharony, Reuven ; Dayan, Dikla ; Kidron, Debora ; Manor, Mira ; Berkovitz, Arie ; Biron-Shental, Tal ; Maymon, Ron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-52d396fe9f5d00adf7262a3e3007d1a4d75f386a48e363ab3c7c48ecd34322c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Amniocentesis - methods</topic><topic>Amniotic Fluid - chemistry</topic><topic>Biomarkers - analysis</topic><topic>Biomarkers - blood</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fetal Growth Retardation - blood</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Maternal Serum Screening Tests</topic><topic>Maternal-Fetal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>Pregnancy - blood</topic><topic>Pregnancy Complications</topic><topic>Prenatal development</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharony, Reuven</creatorcontrib><creatorcontrib>Dayan, Dikla</creatorcontrib><creatorcontrib>Kidron, Debora</creatorcontrib><creatorcontrib>Manor, Mira</creatorcontrib><creatorcontrib>Berkovitz, Arie</creatorcontrib><creatorcontrib>Biron-Shental, Tal</creatorcontrib><creatorcontrib>Maymon, Ron</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharony, Reuven</au><au>Dayan, Dikla</au><au>Kidron, Debora</au><au>Manor, Mira</au><au>Berkovitz, Arie</au><au>Biron-Shental, Tal</au><au>Maymon, Ron</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</atitle><jtitle>Archives of gynecology and obstetrics</jtitle><stitle>Arch Gynecol Obstet</stitle><addtitle>Arch Gynecol Obstet</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>293</volume><issue>4</issue><spage>767</spage><epage>770</epage><pages>767-770</pages><issn>0932-0067</issn><eissn>1432-0711</eissn><abstract>Purpose
The use of maternal serum alpha fetoprotein (MSAFP) levels as a predictor of pregnancy complications (PC) is well established. We hypothesized that the ratio between the MSAFP/AFAFP levels (RATIO) will more accurately predict PC than MSAFP levels alone.
Methods
Women who had a MSAFP test followed by amniocentesis were divided into two groups: those who had PC comprised the study group and those who had an uneventful pregnancy served as the control group. Data regarding pregnancy and delivery course were collected. The RATIO between the study and the control groups was compared.
Results
166 women were included in the study, of which 24 had PC. A significant correlation was found between the RATIO and intrauterine growth restriction (IUGR) and week of delivery. Six pregnancies had elevated MSAFP levels; two with RATIO below 2 had uneventful pregnancies. Among the other four pregnancies with RATIO above two, one had IUGR and the other, placental abruption.
Conclusion
Our data suggest that the RATIO might serve as a predictor of IUGR and week of delivery. Although the number of patients in the current study was relatively small, the novelty of the proposed simple marker implies that a larger scale study is warranted. Such studies may confirm this finding and a possible advantage of using this RATIO instead of or in addition to MSAFP values for better prediction of pregnancies at risk for PC.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26453361</pmid><doi>10.1007/s00404-015-3905-9</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0932-0067 |
ispartof | Archives of gynecology and obstetrics, 2016-04, Vol.293 (4), p.767-770 |
issn | 0932-0067 1432-0711 |
language | eng |
recordid | cdi_proquest_miscellaneous_1774526069 |
source | MEDLINE; SpringerNature Journals |
subjects | Adult alpha-Fetoproteins - analysis Amniocentesis - methods Amniotic Fluid - chemistry Biomarkers - analysis Biomarkers - blood Endocrinology Female Fetal Growth Retardation - blood Gynecology Human Genetics Humans Maternal Serum Screening Tests Maternal-Fetal Medicine Medicine Medicine & Public Health Obstetrics/Perinatology/Midwifery Pregnancy - blood Pregnancy Complications Prenatal development Retrospective Studies |
title | Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A27%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20ratio%20of%20maternal%20serum%20to%20amniotic%20fluid%20AFP%20superior%20to%20serum%20levels%20as%20a%20predictor%20of%20pregnancy%20complications?&rft.jtitle=Archives%20of%20gynecology%20and%20obstetrics&rft.au=Sharony,%20Reuven&rft.date=2016-04-01&rft.volume=293&rft.issue=4&rft.spage=767&rft.epage=770&rft.pages=767-770&rft.issn=0932-0067&rft.eissn=1432-0711&rft_id=info:doi/10.1007/s00404-015-3905-9&rft_dat=%3Cproquest_cross%3E2261525731%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2261525731&rft_id=info:pmid/26453361&rfr_iscdi=true |